Deutsche Bank Ag\ Hepion Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.15 - $5.74 $8,089 - $40,375	-7,034 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.25 - $6.99 $15,801 - $49,090	7,023 Added 63845.45%	7,034 $37,000
Q3 2019 Nov 14, 2019	BUY	$2.09 - $4.12 $22 - $45	11 New	11 $0

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.